Stratagent Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 30-12-2024
- Paid Up Capital ₹ 0.10 M
as on 30-12-2024
- Company Age 6 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 7066.90%
(FY 2020)
- Profit 133.20%
(FY 2020)
- Ebitda 4807.87%
(FY 2020)
- Net Worth 17.96%
(FY 2020)
- Total Assets 1014.29%
(FY 2020)
About Stratagent Life Sciences
The Company is engaged in the Jewelry & Fashion Accessories Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sambamoorthy Papudesi, Venkatesh Vellicety, Jambals Madhu, and One other member serve as directors at the Company.
- CIN/LLPIN
U33309KA2018PTC114556
- Company No.
114556
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jul 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Stratagent Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkatesh Vellicety  | Managing Director | 06-Jul-2018 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sambamoorthy Papudesi | Additional Director | 23-Oct-2024 | Current |
| Jambals Madhu | Additional Director | 23-Oct-2024 | Current |
| Pedireddy Prabhakar | Additional Director | 23-Oct-2024 | Current |
Financial Performance of Stratagent Life Sciences.
Stratagent Life Sciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 7066.9% increase. The company also saw a substantial improvement in profitability, with a 133.2% increase in profit. The company's net worth Soared by an impressive increase of 17.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stratagent Life Sciences?
Unlock access to Stratagent Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Dalogix Technologies Private LimitedActive 10 years 6 monthsSambamoorthy Papudesi is a mutual person
- Stratagent Pharma Labs Private LimitedActive 2 years 8 months
Venkatesh Vellicety is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Stratagent Life Sciences?
Unlock and access historical data on people associated with Stratagent Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stratagent Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stratagent Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
